Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC

JSE Share Code: MEI
NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

('Mediclinic', the 'Company' or the 'Group')

23 June 2017

POSTING OF ANNUAL REPORT AND FINANCIAL STATEMENTS, NOTICE OF ANNUAL GENERAL MEETING AND PROXY FORM

Mediclinic's Annual Report and Financial Statements in respect of the financial year ended 31March 2017 ('2017 Annual Report') is being posted to shareholders during the course of today, together with the Notice of Annual General Meeting and Form of Proxy in relation to the Company's annual general meeting to be held on Tuesday, 25 July 2017 at the Rosewood London Hotel, 252 High Holborn, London, WC1V 7EN at 15:00 (BST).

In accordance with Listing Rule 9.6.1, the above documents will be submitted to the UK Listing Authority via a National Storage Mechanism and will shortly be available to the public for inspection atwww.morningstar.co.uk/NSM.

The documents will also be made available on the Company's website atwww.mediclinic.comduring the course of today.

The Company released its preliminary results on 24 May 2017 (RNS No. 0335G), and this announcement should be read in conjunction with that announcement. The financial information contained in the preliminary results announcement does not constitute the Company's statutory accounts for the years ended 31 March 2016 and 2017, but is derived from those accounts. Statutory accounts for year ended 31 March 2017 will be delivered to the Registrar of Companies in due course. The Company's auditors have reported on those accounts; their report was (i) unqualified, (ii) did not include a reference to any matters to which the auditors drew attention by way of emphasis without qualifying their report, and (ii) did not contain a statement under Section 498(2) or (3) of the Companies Act 2006. The text of the auditors' report can be found in the Company's 2017 Annual Report.

About Mediclinic International plc

Mediclinic is an international private healthcare group with operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a LSE listed and UK-based private healthcare group.

Mediclinic comprises 74 hospitals and 37 clinics. Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 000 inpatient beds in total; Hirslanden operates 16 private acute care facilities and 4 clinics in Switzerland with more than 1 600 inpatient beds; and Mediclinic Middle East operates 6 hospitals and 31 clinics with more than 700 inpatient beds in the United Arab Emirates.

During February 2016, the combination of the Company (previously named Al Noor Hospitals Group plc), with operations mainly in Abu Dhabi in the United Arab Emirates, and Mediclinic International Limited was completed. Mediclinic International Limited was a South African based international private healthcare group founded in 1983 and listed on the JSE, the South African stock exchange, since 1986, with operations in South Africa, Namibia, Switzerland and the United Arab Emirates (mainly in Dubai). The combination resulted in the renaming of the enlarged group to Mediclinic International plc.

Mediclinic has a primary listing on the Main Market of the LSE, with secondary listings on the JSE in South Africa and the NSX in Namibia.

For further information, please contact:

Capita Company Secretarial Services Limited

Victoria Dalby

+44 (0)207 954 9600

Investor Relations, Mediclinic International plc

James Arnold, Head of Investor Relations

ir@mediclinic.com

+44 (0)20 3786 8181

Media queries

FTI Consulting

Brett Pollard/Debbie Scott (UK)

+44 (0)20 3727 1000

Frank Ford (South Africa)

+27 (0)21 487 9000

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website:www.mediclinic.com

Corporate broker: Morgan Stanley & Co International plc

JSE sponsor:RAND MERCHANT BANK (A division of FirstRand Bank Limited)

NSX sponsor:Simonis Storm Securities (Pty) Ltd

Mediclinic International plc published this content on 23 June 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 23 June 2017 10:09:09 UTC.

Original documenthttp://ir.mediclinic.com/phoenix.zhtml?c=145797&p=irol-rnsArticle&ID=2282774

Public permalinkhttp://www.publicnow.com/view/23E3C92BC043FC3F0CD8D4E8FC6B8892DF9A5886